Twist Bioscience Corporation
TWST
Classificação em ações
#2285
Twist Bioscience Corporation operates as a leading synthetic biology firm,... Twist Bioscience Corporation operates as a leading synthetic biology firm, specializing in the production and sale of products developed from synthesized DNA. The company utilizes a unique DNA synthesis platform that facilitates the creation of artificial DNA by "writing" it directly onto silicon chips. Its extensive product catalog encompasses custom synthetic genes, specialized tools designed for sample preparation, comprehensive antibody libraries essential for pharmaceutical research and development, and advanced applications leveraging DNA for digital data storage. Twist Bioscience has established strategic collaborations with several organizations, including Victorian Clinical Genetic Services, Vivlion GmbH, Kyowa Kirin Pharmaceutical Research, Inc., deepCDR Biologics AG, and Centogene N.V., with the shared goal of innovating advanced sequencing technologies. Furthermore, the company engages in a research alliance with Boehringer Ingelheim International GmbH, where it applies its exclusive antibody libraries to identify and develop therapeutic antibodies against a multitude of targets. The corporation was founded in 2013 and is headquartered in South San Francisco, California.
Preço da ação
$135.09
Valor de mercado
$8.89B
Variação (1 dia)
1.76%
Variação (1 ano)
379.72%
País
US
Negociar Twist Bioscience Corporation (TWST)
Categoria
Healthcare
EPS de Twist Bioscience Corporation (TWST)
EPS em June 2026 TTM: $-2.22
De acordo com os últimos relatórios financeiros e o preço das ações da Twist Bioscience Corporation, o EPS atual da empresa (TTM) é $-2.22. No final de 2024, a empresa teve um EPS de $-3.60, igual a ao EPS de 2023, que foi de $-3.60.
Histórico de EPS da Twist Bioscience Corporation de 2016 até 2026
EPS no final de cada ano
| Ano | EPS | Alterar |
|---|---|---|
| 2026 (TTM) | $-2.22 | 70.77% |
| 2025 | $-1.30 | -63.89% |
| 2024 | $-3.60 | 0.00% |
| 2023 | $-3.60 | -10.89% |
| 2022 | $-4.04 | 28.25% |
| 2021 | $-3.15 | -11.76% |
| 2020 | $-3.57 | -8.93% |
| 2019 | $-3.92 | 46.27% |
| 2018 | $-2.68 | -15.19% |
| 2017 | $-3.16 | 34.47% |
| 2016 | $-2.35 | 0.00% |
EPS de empresas semelhantes ou concorrentes
| Empresa | EPS | Diferença de EPS | País |
|---|---|---|---|
| $18.62 | -938.74% |
US
|
|
| $5.65 | -354.50% |
US
|
|
| $-1.36 | -38.74% |
US
|
|
| - | - |
CN
|
|
| $5.09 | -329.28% |
US
|
